Updated May 24, 2026 · 608 articles

Research

Quarterly deep analysis of institutional holdings, hedge fund strategies, and market trends from SEC 13F filings.

Sorted by most recent · 608 results

May 24, 2026

Conestoga Capital 13F (2026 Q1): A Small-Cap Growth Specialist

Conestoga Capital focuses on small-cap growth, the niche, under-followed companies index funds can't reach. Its 2026 Q1 book of quality small-caps, RBC Bearings, Casella, Balchem, is evenly weighted by discipline, with broad trims signaling outflows and a new FirstService stake.

Tortoise Capital 13F (2026 Q1): A Pure Energy-Infrastructure Book

Tortoise Capital doesn't dabble in energy, it specializes. Its 2026 Q1 13F is a pure midstream book of pipelines, processing, and LNG export, led by Targa, Williams and Energy Transfer, with a Cheniere add. Learn why the fee-based toll-road model draws a specialist, and the sector-bet risk.

Mawer 13F (2026 Q1): A Global-Quality Book in Broad Retreat

Mawer, the Calgary firm whose motto is be boring, make money, runs a patient global-quality book. Its 2026 Q1 US filing shows broad retreat, nearly every major position trimmed and reported value down from $22B to $15B, the fingerprint of outflows rather than lost conviction.

Mairs & Power 13F (2026 Q1): Megacaps and a Minnesota Tilt

Mairs & Power has managed money from St. Paul since 1931, and its book carries a hometown accent. Its 2026 Q1 13F pairs a megacap-tech core, Nvidia, Microsoft, Amazon, with prominent Minnesota industrials like Graco and Toro, a quality-growth discipline rooted in local knowledge.

Westwood Global 13F (2026 Q1): 12 Stocks, Mostly Latin America

Westwood Global runs emerging-markets investing the rare way: just 12 high-conviction positions, mostly Latin American. Its 2026 Q1 book is anchored by Credicorp and Itaú, with a 78% add to Argentina's Grupo Galicia and a new Yum China stake, a focused regional wager, not diversified EM.

First Pacific Advisors 13F (2026 Q1): Value With a Quality Streak

First Pacific Advisors occupies the middle ground of value investing, owning unloved value names and high-quality compounders side by side when the price is right. Its 2026 Q1 book pairs Analog Devices and Alphabet with Citigroup and Comcast, while trimming several winners.

Pinnacle Associates 13F (2026 Q1): Stocks and ETFs Side by Side

Pinnacle Associates' 2026 Q1 13F blends hand-picked megacaps, Johnson & Johnson, Apple, Nvidia, with broad-market index ETFs like SPY, VTI and a new Nasdaq-100 sleeve. A core-satellite book that shows where the firm bets actively and where it is content to own the market.

Crawford Investment 13F (2026 Q1): An Income-and-Quality Book

Crawford Investment Counsel builds around high-quality companies that pay and grow reliable dividends. Its 2026 Q1 book spreads $5.85B across 300 income payers, with a utility-and-staples backbone, AbbVie, AstraZeneca, AEP, Philip Morris, and a new AstraZeneca stake.

Cardinal Capital 13F (2026 Q1): A Canadian Blue-Chip Book

Cardinal Capital's 2026 Q1 13F reads like the Toronto exchange: a concentrated 66-stock book anchored by Suncor, the big Canadian banks, pipelines and life insurers. A dividend-rich bet on Canada's resource and financial economy, headlined by a doubling of its Sun Life position.

Auxier 13F (2026 Q1): A Capital-Preservation Value Book

Jeff Auxier runs money to protect capital first and let returns follow. His 2026 Q1 book spreads $696M across 176 mostly defensive names, Philip Morris, Kroger, Walmart, Microsoft, J&J, with only light trims, the texture of a downside-aware, capital-preservation strategy.

Beck Mack & Oliver 13F (2026 Q1): A Bet on Private Capital

Beck Mack & Oliver, a New York firm dating to the 1930s, leans into a modern theme in 2026 Q1: the rise of the alternative-asset managers. Its book is led by Apollo and Blackstone, with Schwab and Gallagher alongside, a quality-financials tilt toward private-market finance.

Broad Run 13F (2026 Q1): A 24-Stock Book, One 21% Bet

Broad Run takes concentration literally: 24 positions, with AST SpaceMobile alone at 21% of the book. Its 2026 Q1 filing pairs that outsized, speculative bet with a core of quality compounders, Applied Materials, Brookfield, Markel, O'Reilly, conviction expressed without a safety net.

Cullen Capital 13F (2026 Q1): A High-Dividend Value Book

Cullen invests in value through the dividend lens, favoring large, cash-returning businesses that pay above-market yields at modest valuations. Its 2026 Q1 book spreads $9.75B across 213 dividend payers, pharma, banks, utilities and energy, with nothing above 3.2%.

Fenimore (FAM) 13F (2026 Q1): A Quality-Compounder Book

Fenimore's FAM Funds buy well-run, durable businesses and hold them for years. Its 2026 Q1 book spreads $4.48B across 92 quality compounders, Ross Stores, Amphenol, Stryker, Fastenal, Markel, with only light trims, the texture of a patient, low-turnover strategy.

Weitz 13F (2026 Q1): Omaha Quality-Value, Anchored by Berkshire

Wally Weitz built one of Omaha's most respected value shops, and his 2026 Q1 book is fittingly anchored by Berkshire Hathaway. A focused, quality-tilted portfolio held steady this quarter, with one clear move: a 16% add to Microsoft.

Jensen 13F (2026 Q1): A Strict-Quality Fund Trims Megacap Tech

Jensen only owns businesses that have earned 15%-plus return on equity for ten straight years. Its 2026 Q1 book of proven compounders shows the firm de-risking megacap tech, trimming Apple and Nvidia, even as sustained outflows have halved its reported assets.

Cooke & Bieler 13F (2026 Q1): A Diffuse Value Book

Cooke & Bieler, a long-established Philadelphia value boutique, runs a diffuse 100-name book where no stock tops 4%. Its 2026 Q1 filing leans heavily on specialty insurers, RenaissanceRe, White Mountains, Arch, which it trimmed, alongside a new Sunbelt Rentals stake.

Kahn Brothers 13F (2026 Q1): Deep Value in the Graham Tradition

Kahn Brothers, founded by Benjamin Graham's own teaching assistant Irving Kahn, practices deep value in its purest, most contrarian form. Its concentrated 2026 Q1 book is led by Citigroup and Bayer, with hard trims in Merck and BP and a new Zillow stake.

Davenport 13F (2026 Q1): How to Read an Advisor's Whole Book

Davenport's 13F is not a hedge fund's conviction book but a Virginia wealth advisor's aggregated holdings, about 500 names where nothing tops 2.4%. Read as a barometer of broad allocation, its 2026 Q1 drift tilted toward megacap tech, Berkshire and managed care.

Chilton Investment 13F (2026 Q1): A Quality Core, Retail Trimmed

Chilton's 2026 Q1 filing lists about 280 names, but a concentrated quality core does the work, with the top ten above half of value. The quarter's moves show a measured rotation: trimming Costco and Home Depot while adding 57% more Amazon.

← PreviousPage 3 of 31Next →